Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein (2023)

First Author: Upasani V
Attributed to:  Broadly neutralising antibodies after vaccination funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/cid/ciad368

Publication URI: http://dx.doi.org/10.1093/cid/ciad368

Type: Journal Article/Review

Parent Publication: Clinical Infectious Diseases

Issue: 7